Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of IVIEW-1201 in adenoviral conjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoviral Conjunctivitis

Drugs mentioned

• IVIEW-1201

Snippet

Sponsor: IVIEW Therapeutics Inc. | Conditions: Adenoviral Conjunctivitis | Phase 2 | Status: COMPLETED